Lee Ainslie Maverick Capital
Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$5.11B |
| 2 |
T-Mobile US
TMUS
|
+$145M |
| 3 |
Amazon
AMZN
|
+$116M |
| 4 |
LPL Financial
LPLA
|
+$108M |
| 5 |
International Flavors & Fragrances
IFF
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$314M |
| 2 |
Meta Platforms (Facebook)
META
|
+$220M |
| 3 |
Applied Materials
AMAT
|
+$190M |
| 4 |
Lam Research
LRCX
|
+$152M |
| 5 |
Alibaba
BABA
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 55.3% |
| 2 | Healthcare | 12.47% |
| 3 | Technology | 11.12% |
| 4 | Communication Services | 7.76% |
| 5 | Financials | 5.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Coupang
CPNG
$29.6B
| $5.03B | 46.38% |
+110,527,590
| New | +$5.11B |
|
2
Microsoft
MSFT
$3.59T
| $282M | 2.6% |
1,196,206
-243,103
| -17% | -$56.4M |
|
|
3
Amazon
AMZN
$2.79T
| $274M | 2.52% |
1,768,260
+731,020
| +70% | +$116M |
|
4
Seer Inc
SEER
$112M
| $262M | 2.41% |
5,419,843
-5,670
| -0.1% | -$332K |
|
|
5
Meta Platforms (Facebook)
META
$1.4T
| $237M | 2.18% |
804,933
-816,009
| -50% | -$220M |
|
6
Alphabet (Google) Class C
GOOG
$4.18T
| $225M | 2.07% |
2,173,320
-707,380
| -25% | -$70.2M |
|
7
Netflix
NFLX
$331B
| $212M | 1.95% |
4,059,100
+1,163,060
| +40% | +$61.7M |
|
|
8
Applied Materials
AMAT
$391B
| $187M | 1.72% |
1,396,882
-1,718,448
| -55% | -$190M |
|
|
9
Lam Research
LRCX
$393B
| $171M | 1.58% |
2,879,890
-2,790,590
| -49% | -$152M |
|
|
10
CALL
Meta Platforms (Facebook)
META
$1.4T
| $162M | 1.49% |
+550,000
| New | +$148M |
|
11
Corpay
CPAY
$27.4B
| $147M | 1.35% |
546,450
-433,088
| -44% | -$118M |
|
|
12
T-Mobile US
TMUS
$196B
| $144M | 1.33% |
+1,148,072
| New | +$145M |
|
13
TG Therapeutics
TGTX
$8.31B
| $143M | 1.32% |
2,971,136
-230,925
| -7% | -$11.1M |
|
|
ONEM
14
DELISTED
1Life Healthcare
ONEM
| $143M | 1.32% |
3,661,204
| – | – |
|
15
XP
XP
$8.53B
| $129M | 1.19% |
3,414,863
+1,498,857
| +78% | +$64M |
|
|
16
LPL Financial
LPLA
$28.5B
| $121M | 1.12% |
852,007
+846,835
| +16,373% | +$108M |
|
17
Nektar Therapeutics
NKTR
$2.53B
| $117M | 1.08% |
390,554
-53,154
| -12% | -$16.5M |
|
18
Humana
HUM
$45.5B
| $113M | 1.04% |
269,855
-16,467
| -6% | -$6.57M |
|
19
Alnylam Pharmaceuticals
ALNY
$31.6B
| $112M | 1.04% |
796,234
-188,268
| -19% | -$28.3M |
|
|
20
International Flavors & Fragrances
IFF
$21.5B
| $111M | 1.02% |
+794,841
| New | +$103M |
|
21
Crown Holdings
CCK
$13B
| $106M | 0.98% |
1,093,066
-425,291
| -28% | -$41M |
|
22
Aon
AON
$75.3B
| $101M | 0.93% |
439,355
+438,177
| +37,197% | +$96.5M |
|
23
Atara Biotherapeutics
ATRA
$97.4M
| $96.8M | 0.89% |
269,576
-23,406
| -8% | -$10.3M |
|
24
Uber
UBER
$161B
| $88.4M | 0.81% |
1,621,364
+1,092,785
| +207% | +$61M |
|
25
LivaNova
LIVN
$4.34B
| $86.1M | 0.79% |
1,168,434
-500,488
| -30% | -$35.7M |
|
Similar funds
Lee Ainslie's Q1 2021 Portfolio in Review
As of Q1 2021, Lee Ainslie held 930 positions worth $10.9B, up 74% from $6.25B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Lee Ainslie deployed $4.39B of net new capital in Q1 2021, opening 269 new positions and adding to 166 existing holdings. Its largest new stake was Coupang: 110,527,590 shares worth $5.03B.
By sector, the portfolio is most concentrated in Consumer Discretionary at 55% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $314M trimmed.
- Lee Ainslie's largest Q1 2021 buy was Coupang: 110,527,590 shares worth $5.03B.
- Lee Ainslie added most to Amazon in Q1 2021, an estimated $116M increase.
- Lee Ainslie's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $314M.
- Lee Ainslie fully exited Perspecta Inc. Common Stock in Q1 2021, selling an estimated $110M.
- Lee Ainslie's ten largest holdings make up 65% of its $10.9B portfolio in Q1 2021.
- Lee Ainslie opened 269 new positions and closed 242 in Q1 2021.
- Lee Ainslie's portfolio value rose 74% quarter-over-quarter to $10.9B.
Based on Maverick Capital's 13F filing for Q1 2021, filed 17 May 2021.